Enzolytics Inc (ENZC)

[foxi]

Here are some of the ITV-1 players:

Scendea - regulatory and "clinical development plan"
Danhson - product production
Clinic Design - clinical trials

https://finance.yahoo.com/news/enzolytics-reports-engagement-scendea-usa-123000633.html


Afaik some of the debt comes from years in the past before ENZC was ENZC, and also some from the early years of ENZC. I assume the $29.5 Million includes old debt currently held in ENZC subsidiaries as well, though maybe not:

The Company has incurred an operating losses since inception and as of December 31, 2020, the Company has incurred accumulated deficit of $29,533,234.
http://www.otcmarkets.com/otcapi/company/financial-report/327646/content

No stock buyback as far as I can tell. What they spent that money on is anyone's guess but presumably they've been operating in (rented?) labs and offices for years, business traveling, patent and legal fees, paying for AI analysis, buying lab equipment and so on. Since 2020, salaries for the main four ENZC executives are $120,000 apiece per year, plus additional stock options, which all contributes to the accumulated deficit. (Earlier salaries were close to six figures as well, best I can tell.)


Samsung is helping with the mAbs side of things. There were rumors from a Chandra tweet in September '21 that turned into news in October.

https://www.bloomberg.com/press-releases/2021-10-07/enzolytics-inc-and-samsung-biologics-announce-development-and-manufacturing-agreement-for-anti-hiv-and-anti-sars-cov-2